Article

Safilo Group renews Nine West licensing

Safilo Group announced the renewal of its exclusive licensing agreement with Jones Apparel Group to design, manufacture, and market prescription eyeglass frames for women and children, as well as women's prescription sunglass frames under the Nine West brand.

Key Points

Padova, Italy-Safilo Group announced the renewal of its exclusive licensing agreement with Jones Apparel Group to design, manufacture, and market prescription eyeglass frames for women and children, as well as women's prescription sunglass frames under the Nine West brand. Safilo Group has been a licensee of the Nine West brand for prescription eyewear since 1998.

The 3-year renewal, which went into effect Jan. 1, includes distribution rights in the United States, its territories and possessions, Canada, China, and Mexico, with the possibility of extending the renewal for a further 3-year period if certain conditions are met.

"Nine West has been recognized as the number one optical brand among women in terms of highest brand share in units. The collection has been extremely well received by the consumer since its inception 10 years ago and has continued to grow exponentially," said Massimiliano Tabacchi, executive vice-chairman of Safilo Group. "Our partnership with Jones Apparel Group and the Nine West brand has been an incredible and successful journey, which we are very pleased to continue."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.